Houman Jalaie

Enantiodiscrimination by a quinine-based chiral stationary phase: a computational study.

Homology model directed alignment selection for comparative molecular field analysis: application to photosystem II inhibitors.

Comparative molecular field analysis of quinine derivatives used as chiral selectors in liquid chromatography: 3D QSAR for the purposes of molecular design of chiral stationary phases.

Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy.

Conditional probability: a new fusion method for merging disparate virtual screening results.

Prediction of drug-like molecular properties: modeling cytochrome p450 interactions.

The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.

Discovery of novel non-peptidic ketopiperazine-based renin inhibitors.

Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors.

Benzyl ether structure-activity relationships in a series of ketopiperazine-based renin inhibitors.

QT interval prolongation: and the beat goes on.

Ketopiperazine-based renin inhibitors: optimization of the "C" ring.

Ashworth Scales are unreliable for the assessment of muscle spasticity.

Virtual screening: are we there yet?

Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.

A randomized, single blind placebo controlled clinical trial on the effect of continuous ultrasound on low back pain.

Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.

Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.

Correlation of sperm nuclear chromatin condensation staining method with semen parameters and sperm functional tests in patients with spinal cord injury, varicocele, and idiopathic infertility.

A preliminary study into the effect of low-intensity pulsed ultrasound on chronic maxillary and frontal sinusitis.

The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect.

Concentration of blood and seminal plasma elements and their relationships with semen parameters in men with spinal cord injury.

Characterization of cytochrome P450-mediated bioactivation of a compound containing the chemical scaffold, 4,5-dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide), to a chemically reactive p-chlorophenyl isocyanate intermediate in human liver microsomes.

Hamstring flexibility in young women following passive stretch and muscle energy technique.

Low back pain during pregnancy in Iranian women: Prevalence and risk factors.

The flexible alignment of molecular structures using simulated annealing with weighted Lagrangian multipliers.

Mistake on quantifying the indirect treatment effect via surrogate markers by Y. Qu and M. Case Statistics in Medicine 2006; 25:223-231.

Validation of a Mini-Mental State Examination (MMSE) for the Persian population: a pilot study.

Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.

A randomized, double-blind clinical trial comparing the effects of continuous and pulsed ultrasound in patients with chronic rhinosinusitis.

The beneficial effects of adding low level laser to ultrasound and exercise in Iranian women with shoulder tendonitis: a randomized clinical trial.

Technical challenges and anatomic anomalies encountered during aortic surgery.

Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer.

Intra-rater reliability of the Modified Modified Ashworth Scale (MMAS) in the assessment of upper-limb muscle spasticity.

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer.